Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma
AstraZeneca
AstraZeneca
University of Maryland, Baltimore
Medical University of Vienna
Hoffmann-La Roche
GlaxoSmithKline
Tampere University Hospital